Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease

Parkinson’s disease (PD) is a growing burden worldwide, and there is no reliable biomarker used in clinical routines to date. Cerebrospinal fluid (CSF) is routinely collected in patients with neurological symptoms and should closely reflect alterations in PD patients’ brains. Here, we describe a sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Karayel, Ozge, Virreira Winter, Sebastian, Padmanabhan, Shalini, Kuras, Yuliya I., Vu, Duc Tung, Tuncali, Idil, Merchant, Kalpana, Wills, Anne-Marie, Scherzer, Clemens R., Mann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245058/
https://www.ncbi.nlm.nih.gov/pubmed/35732154
http://dx.doi.org/10.1016/j.xcrm.2022.100661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245058/
https://www.ncbi.nlm.nih.gov/pubmed/35732154
http://dx.doi.org/10.1016/j.xcrm.2022.100661

Ejemplares similares